HUM
Humana Inc
NYSE: HUM · HEALTHCARE · HEALTHCARE PLANS
$239.67
+0.72% today
Updated 2026-05-05
Market cap
$28.05B
P/E ratio
24.93
P/S ratio
0.20x
EPS (TTM)
$9.37
Dividend yield
1.50%
52W range
$162 – $312
Volume
1.8M
WallStSmart proprietary scores
59
out of 100
Grade: C+
Hold
Investment rating
6.0
Growth
B7.5
Quality
B+4.5
Profitability
C7.3
Valuation
B+4/9
Piotroski F-Score
Moderate
4.4
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$240.50
+0.35%
12-Month target
$171.20
-28.57%
Intrinsic (DCF)
$1,141.73
Margin of safety
+80.96%
2 Strong Buy6 Buy16 Hold2 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 4.37 — safe zone
+ Free cash flow $1.13B — positive
+ Revenue growth 23.50% QoQ
+ 80.96% below intrinsic value
Risks
- Thin margins at 0.82%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $92.92B | $106.44B | $117.81B | $129.66B | $137.20B | $163.6B |
| Net income | $2.81B | $2.49B | $1.21B | $1.19B | $1.19B | — |
| EPS | — | — | — | — | $9.37 | $9.33 |
| Free cash flow | $3.47B | $2.98B | $2.39B | $375.00M | $1.13B | — |
| Profit margin | 3.02% | 2.34% | 1.02% | 0.92% | 0.82% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-01 | SHETTY, SANJAY K | Buy | 887 | — |
| 2026-04-01 | SHETTY, SANJAY K | Sale | 401 | $175.44 |
| 2026-03-31 | RENAUDIN, GEORGE II | Buy | 25 | $173.39 |
Peer comparison
Smart narrative
Humana Inc trades at $239.67. representing a P/E of 24.93x trailing earnings. Our Smart Value Score of 59/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 4.37, it sits in the safe zone. TTM revenue stands at $137.20B. with profit margins at 0.82%. Our DCF model estimates intrinsic value at $1,141.73.
Frequently asked questions
What is Humana Inc's stock price?
Humana Inc (HUM) trades at $239.67.
Is Humana Inc overvalued?
Smart Value Score 59/100 (Grade C+, Hold). DCF value $1,141.73.
What is the price target of Humana Inc (HUM)?
The analyst target price is $240.50, representing +0.3% upside from the current price of $239.67.
What is the intrinsic value of Humana Inc (HUM)?
Based on our DCF model, intrinsic value is $1,141.73, a +81.0% margin of safety versus $239.67.
What is the future stock price of HUM by 2030?
Our research-backed model estimates Humana Inc could reach $882.10 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Humana Inc's revenue?
TTM revenue is $137.20B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
4.37 — safe zone.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.20x
ROE6.28%
Beta0.45
50D MA$189.48
200D MA$240.44
Shares out0.12B
Float0.12B
Short ratio—
Avg volume1.8M
Performance
1 week-1.42%
1 month+31.22%
3 months+24.78%
YTD-6.43%
1 year—
3 years—
5 years—